These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2887615)

  • 21. [Strong inhibition of gastric acid secretion: when is it justifiable?].
    Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
    G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
    Stabile BE; Ippoliti AF; Walsh JH; Passaro E
    Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol Suppl; 1989; 166():95-100; discussion 111-3. PubMed ID: 2574912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncertainties in the management of the Zollinger-Ellison Syndrome.
    Malagelada JR
    Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
    [No Abstract]   [Full Text] [Related]  

  • 25. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
    Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
    Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring.
    Vallot T; Mignon M; Mazure R; Bonfils S
    Dig Dis Sci; 1983 Jul; 28(7):577-84. PubMed ID: 6305607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of patients with Zollinger-Ellison syndrome who have had previous gastric surgery: a prospective study.
    Maton PN; Frucht H; Vinayek R; Wank SA; Gardner JD; Jensen RT
    Gastroenterology; 1988 Feb; 94(2):294-9. PubMed ID: 3335308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ranitidine in the medical treatment of Zollinger-Ellison syndrome.
    Bonfils S; Mignon M; Vallot ; Mayeur S
    Scand J Gastroenterol Suppl; 1981 Jun; 69():119-23. PubMed ID: 6119775
    [No Abstract]   [Full Text] [Related]  

  • 30. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Kloeti G
    Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cimetidine pharmacokinetics in patients with Zollinger-Ellison syndrome.
    McArthur KE; Raufman JP; Seaman JJ; Ziemniak JA; Gardner JD; Jensen RT
    Gastroenterology; 1987 Jul; 93(1):69-76. PubMed ID: 3582917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD; Grant SM; Goa KL
    Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
    Metz DC; Strader DB; Orbuch M; Koviack PD; Feigenbaum KM; Jensen RT
    Aliment Pharmacol Ther; 1993 Dec; 7(6):597-610. PubMed ID: 8161665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Danne O; Maria J
    Nouv Presse Med; 1977 Nov; 6(38):3544-5. PubMed ID: 23518
    [No Abstract]   [Full Text] [Related]  

  • 38. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of metastatic Zollinger-Ellison syndrome with high-dose H2-receptor antagonists.
    Johnston SR; Wright PL
    Br J Clin Pract; 1990 Dec; 44(12):792-3. PubMed ID: 2102253
    [No Abstract]   [Full Text] [Related]  

  • 40. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome.
    Howard TJ; Passaro E
    Surg Annu; 1990; 22():93-106. PubMed ID: 2408174
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.